בקרוב בישראל: בדיקת שתן לגילוי סרטן הערמונית

caterpiler · Points : 1549 Registration date : 15.09.20

סרטן הערמונית הוא הסרטן השני בשכיחותו הגורם לתמותה בקרב גברים, ולמרות שהוא ניתן לריפוי אם מאובחן בשלב מוקדם, רבים ממאנים להיבדק. בדיקת שתן חדשה שנבדקה במחקר רחב היקף עתידה להגיע לישראל עד סוף השנה: "שיפור עצום בחוויית המטופל. שואפים להורדה בתחלואה הניתנת למניעה"

biomarker

biomarker

satworld forum member

Points : 1536
Registration date : 15.09.20

MicroRNA Expression Profiles Identify Clinically Significant Prostate Cancer
Laurence Klotz, MD, discusses a liquid biopsy urine test that uses microRNA expression profiles to identify clinically significant prostate cancer in patients. He emphasizes the ease and efficiency of the technology, in addition to its high degree of sensitivity and specificity.

Read more here: https://grandroundsinurology.com/micr...

https://www.mirscientific.com/

[size=45]Breakthrough, Standalone Liquid Biopsy Urine Test for Prostate Cancer[/size]

https://www.mirscientific.com/mir-advantage

נערך לאחרונה על-ידי biomarker בתאריך Tue Sep 15, 2020 9:58 pm, סך-הכל נערך פעם אחת

biomarker

biomarker

satworld forum member

Points : 1536
Registration date : 15.09.20

MicroRNA Expression Profiles Identify Clinically Significant Prostate Cancer

Genetic Risk Score for Prostate Cancer Screening

Brian T. Helfand, MD, Chief of the Division of Urology at NorthShore University HealthSystem in Evanston, Illinois, discusses the growing role of genetic assessment in prostate cancer screening, emphasizing the benefits of finding patients’ single nucleotide polymorphism (SNP)-based polygenic risk score (PRS). He acknowledges the roles of family history and testing for rare pathogenic mutations like BRCA2, ATM, and CHEK2, but observes that the former can change over time and be difficult to accurately obtain, while the latter is only relevant to a small percentage of patients. PRS, or genetic risk score, is a number calculated based on the cumulative variation across multiple SNPs, which is then used to provide an easily interpreted estimate of disease risk that is more informative than family history, improves predictive performance, and is significantly associated with both prostate cancer incidence and mortality. Dr. Helfand concludes by noting that there are currently no agreed upon guidelines for timing and frequency of PSA testing, but genetic assessment, and particularly PRS, could clarify who would benefit from early screening.

biomarker

biomarker

satworld forum member

Points : 1536
Registration date : 15.09.20

Results of a Prostate Cancer/Vitamin D Trial: Effectiveness Safety Recommendations

Bruce W. Hollis, PhD, Medical University of South Carolina shares the results of a recent trial including identifying the vitamin D level needed to protect the prostate gland. Recorded on 12/09/2014. [3/2015] [Show ID: 29079]

Vitamin D for Public Health - Integrating Sunshine, Supplements and Measurement for Optimal Health 2014
(https://www.uctv.tv/vitamin-d-public-...)

Explore More Health & Medicine on UCTV
(https://www.uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.

UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.
(https://www.uctv.tv)

biomarker

biomarker

satworld forum member

Points : 1536
Registration date : 15.09.20

Nutrition and Prostate Cancer What We Think We Know and What We Actually Know

Dr. Stephen J. Freedland presented "Nutrition and Prostate Cancer: What We Think We Know and What We Actually Know" at the 22nd Annual Scottsdale Prostate Cancer Symposium on Thursday, March 16, 2017.

Read More Here:
https://grandroundsinurology.com/nutr...

biomarker

biomarker

satworld forum member

Points : 1536
Registration date : 15.09.20

Mark A. Moyad MD, MPH, discusses how reducing caloric intake and improving heart health can help patients fight prostate cancer and reduce the odds of recurrent cancer. He also argues that experimenting with supplements along with cancer treatment can be disadvantageous and that over the counter drugs should only be taken with a certificate of analysis. Dr. Moyad further discusses how dietary changes for cancer patients will also improve their heart health, mental health, and quality of life.
State of the Art: Nutrition and Prostate Cancer

בקרוב בישראל: בדיקת שתן לגילוי סרטן הערמונית

1 בקרוב בישראל: בדיקת שתן לגילוי סרטן הערמונית Tue Sep 15, 2020 6:38 pm

caterpiler

2 Re: בקרוב בישראל: בדיקת שתן לגילוי סרטן הערמונית Tue Sep 15, 2020 9:51 pm

biomarker

3 Re: בקרוב בישראל: בדיקת שתן לגילוי סרטן הערמונית Tue Sep 15, 2020 9:53 pm

biomarker

4 Re: בקרוב בישראל: בדיקת שתן לגילוי סרטן הערמונית Tue Sep 15, 2020 9:54 pm

biomarker

5 Re: בקרוב בישראל: בדיקת שתן לגילוי סרטן הערמונית Tue Sep 15, 2020 9:55 pm

biomarker

6 Re: בקרוב בישראל: בדיקת שתן לגילוי סרטן הערמונית Tue Sep 15, 2020 9:57 pm

biomarker